The Bioculture Group specializes in supporting preclinal & translational research. Our Care to Cure model unites ethical animal welfare, scientific excellence & impactful.
Our Integrated Research Ecosystem
The “Care to Cure” Approach:
Bioculture operates an integrated research ecosystem focused on the early stages of biomedical innovation. Our activities are concentrated in discovery and pre-clinical research, where ethical animal care, scientific rigor, and translational insight are most critical.
From responsible primate breeding in Mauritius to advanced preclinical and gene therapy research in the United States, our model ensures consistency, traceability, and scientific integrity, while contributing data and insights that support downstream clinical development, regulatory submission, and long-term therapeutic impact.
Care
Welfare-focused, compassion-driven care
Supply
Ethical & fully regulated export, quarantine, & last mile delivery to customers.
Research
Preclinical and genetic research through Franklin Biolabs & AnewCRO.
Cure
Supporting breakthroughs in drug discovery & medical advancements that save lives worldwide
Our Services
The Bioculture Group operates through two primary service categories that together define our biomedical value chain:
Supply of Non-Human Primates (NHPs):
Ethical breeding, housing, and export of Specific Pathogen Free (SPF) cynomolgus macaques to support global biomedical research. Our integrated operations ensure high standards of animal welfare, veterinary care, biosecurity, and traceability, providing researchers with reliable, well-characterised models that underpin reproducible and responsible preclinical science.
Research Services
Preclinical, translational, and genetic research programs supporting discovery and non-clinical development. Through advanced in vivo models, pharmacology, toxicology, and gene therapy expertise, our research services generate high-quality data that inform downstream clinical development and regulatory pathways.
Our Integrated Research Ecosystem
The “Care to Cure” Approach:
Bioculture operates an integrated research ecosystem focused on the early stages of biomedical innovation. Our activities are concentrated in discovery and pre-clinical research, where ethical animal care, scientific rigor, and translational insight are most critical.
From responsible primate breeding in Mauritius to advanced preclinical and gene therapy research in the United States, our model ensures consistency, traceability, and scientific integrity, while contributing data and insights that support downstream clinical development, regulatory submission, and long-term therapeutic impact.
Supply
Ethical and fully regulated export, quarantine, and last mile delivery to customers.
Supply
Ethical and fully regulated export, quarantine, and last mile delivery to customers.
Supply
Ethical and fully regulated export, quarantine, and last mile delivery to customers.
Supply
Ethical and fully regulated export, quarantine, and last mile delivery to customers.
Supply of NHPs
Bioculture is one of the world’s most respected sources for ethically bred cynomolgus macaques (Macaca fascicularis).
Our SPF (Specific Pathogen Free) colonies in Mauritius represent over 40 years of scientific, genetic, and welfare management.
Importance in Biomedical Research:
Non-human primates remain an essential model for translational medicine. Their physiological similarity to humans provides crucial insight into vaccine development, pharmacokinetics, and toxicology — enabling safer, more effective therapies.
Ethics and Quality:
Every Bioculture primate is raised under internationally certified conditions that prioritize behavioral enrichment, socialization, and positive reinforcement training.
All breeding, transport, and holding operations comply with AAALAC International, USDA, CDC, and Mauritian regulatory standards.
Research Services
Through Franklin Biolabs and AnewCRO, Bioculture provides advanced research capabilities spanning preclinical toxicology, pharmacology, and genetic medicine.
This expansion allows the Group to contribute directly to the discovery and validation of next-generation therapies.
Types of Research Supported:
– Cell and Gene Therapy: AAV, RNA, and viral vector studies supporting IND submissions.
– Biologics and Vaccines: Preclinical safety, PK/PD, and immunogenicity testing.
– CNS and Ocular Research: Specialized surgical and behavioral models in NHPs.
– Discovery Toxicology: Non-GLP studies for candidate selection and early screening.
Scientific Expertise:
Bioculture’s research entities are staffed by leading scientists and CRO professionals with decades of experience in translational research and regulatory compliance.
By combining ethical animal sourcing with controlled laboratory precision, we deliver reproducible data and shorten development timelines for global clients.
Subsidiary Links:
[Franklin Biolabs →] Gene and cell therapy CRO.
[AnewCRO →] NHP-based preclinical research.
Certifications & Compliance
Bioculture Group’s commitment to quality and integrity is embedded in every process — from breeding to data reporting. Our global compliance framework ensures that all operations meet or exceed international research and welfare standards.
Animal care and use
accreditation.
U.S. import and acclimation compliance.
U.S. research and welfare oversight.
Licensing and biodiversity conservation.
Industries We Serve
Partnering in drug discovery, biologics, and vaccine development.
Providing preclinical expertise for gene and cell therapy innovation.
Supporting translational research and ethical scientific training.
Collaborating on infectious disease preparedness and global health research.
